Ledger.Open graph →
SEC Form D · filed December 30, 2013

AV Therapeutics, Inc

Offering
$2.5M
Sold
$660K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Raj K. Tiwari · New York, NYExec · DirectorJan K. Geliebter · New York, NYExecAbraham Mittelman · New York, NYExec · DirectorDuncan Morton · Ketchum, IDExecMorton Coleman · New York, NYExecJohn Walecka · Menlo Park, CAExecBanerjee K. Debabrata · New York, NYExecRobert Pollock · New York, NYExecJudith P. Jayson · Getzville, NYExec · DirectorSteven Heinz · Dublin, IrelandExecCharles Silvey · San Francisco, CAExec · DirectorPeter Wagner · Menlo Park, CAExecDoug Cole · Belle Fourche, SDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗